Welcome to our dedicated page for 1847 Holdings SEC filings (Ticker: EFSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings for 1847 Holdings LLC (EFSH) provide detailed insight into the company’s structure, capital markets activity, and regulatory history as a diversified acquisition holding company. Through its filings, 1847 Holdings describes its strategy of acquiring, enhancing, and monetizing undervalued middle market and lower-middle market businesses, and explains how operating subsidiaries may be sold, taken public, or held to support the company’s ability to pay dividends.
Key documents for EFSH include registration statements and current reports on Form 8-K. A Form S-1/A filed in July 2025 outlines common shares issuable upon exercise of Series A and Series B warrants, including exercise prices, cashless exercise features, a zero exercise price option for Series A warrants, and reset mechanisms tied to volume-weighted average price, share combination events, and subsequent equity sales, all subject to a defined floor price. This filing also discusses prior registration of warrant shares and the need to register additional shares due to adjustments based on the floor price.
Filings related to the company’s exchange listing status are also central for investors. An 8-K dated July 8, 2025, details NYSE American’s decision to commence delisting proceedings for the company’s common shares due to low selling price, the suspension of trading on April 3, 2025, the company’s request for a hearing before a Listing Qualifications Panel, and the Panel’s decision to uphold the delisting determination. A Form 25 filed on July 9, 2025, by NYSE American formally removes the common shares from listing and registration under Section 12(b) of the Exchange Act. The 8-K further notes that the company has submitted an application for quotation of its common shares on the OTCQB Venture Market.
On Stock Titan’s filings page for EFSH, users can review such SEC documents, including registration statements and 8-Ks describing material events like delisting notices and changes in trading venue. The platform’s AI-powered tools can help summarize lengthy filings, highlight key terms such as warrant structures, floor prices, and listing status changes, and make it easier to understand how these disclosures relate to 1847 Holdings’ broader strategy of acquiring, enhancing, and monetizing undervalued businesses.
1847 Holdings LLC (EFSH) disclosed that NYSE American filed a Form 25 to delist its common shares. The company's condensed consolidated financials show a working capital deficit of $87,343,162 and restricted cash of $500,929. For the six months ended June 30, 2025, the Company reported operating income of $2,374,686 and cash flows provided by operating activities from continuing operations of $973,606. The filing also discloses significant convertible notes and other debt balances, including secured convertible promissory notes of $22,819,184 and a combined total debt figure presented as $32,621,283 in the schedules. The report details multiple debt amendments, losses on extinguishment of debt and preferred/share warrant exchanges.
1847 Holdings LLC filed a Form 10-K/A to correct typographical errors in its Section 906 certifications and to furnish new Section 302 certifications; the Amendment states it does not change any other disclosures in the Original 10-K. The filing restates no operating results and directs readers to the Original 10-K for substantive disclosures.
The company describes its acquisition-focused business model targeting small businesses with enterprise value under $50 million, a conservative leverage policy (operating subsidiaries' debt to EBITDA not to exceed 1.25x), a parent management fee equal to 0.5% quarterly (2.0% annualized) of adjusted net assets, and a manager profit allocation structure that can produce a 20% allocation after an 8% annualized hurdle. Key facts: 26,539,774 common shares outstanding as of March 28, 2025; aggregate market value of non-affiliate shares approximately $8.5 million as of June 28, 2024; 6 full-time employees as of December 31, 2024.
Key Filing: Amendment No. 2 to Form S-1 for 1847 Holdings LLC (symbol formerly “EFSH”) dated 10 July 2025. The registration statement covers 778,524,571 common shares to be resold by existing investors who hold Series A and Series B warrants issued in the December 2024 $11.4 million private placement.
Warrant mechanics
- Series A: 507.7 million shares, exercise price $0.81, but holders may use a zero-exercise-price feature to receive 1.25 shares for every share otherwise exercisable. Generates no cash for the company.
- Series B: 270.8 million shares, exercise price $0.54; cash proceeds possible only after Series A warrants are fully exercised. Maximum potential cash to the company is ~$22.8 million.
- Both series carry multiple downward-reset provisions (Share Combination, Registration Reset, Subsequent Equity Sales) but will never fall below a “Floor Price” (currently $0.054).
Capital structure impact
- Company currently has just 32.3 million shares outstanding; the new registration equals ~24× that amount, creating the potential for extreme dilution.
- Additional overhang: 213 million shares tied to preferred conversions, other warrants, notes and plan shares are not included in this resale registration.
Listing status & liquidity
- NYSE American suspended trading on 3 Apr 2025 and filed Form 25 to delist on 9 Jul 2025 due to low share price.
- Company has applied for quotation on the OTCQB Venture Market; until approval, shares are not trading anywhere, limiting investor liquidity.
Financial position & strategy
- Shareholders’ equity deficit was $95.6 million at 31 Mar 2025; management must address this before any future uplisting attempt.
- 1847 Holdings operates as a micro-cap acquisition platform (cabinetry, carpentry, etc.) and is actively marketing its Wolo subsidiary for sale in 2025.
- Management fee structure: 2% of adjusted net assets to external manager plus a 20% profit allocation on subsidiary sales.
Use of proceeds: Company will receive no cash from Series A exercises; potential Series B proceeds are earmarked for working capital and general purposes, but timing is uncertain.
Material risks highlighted: (i) absence of active trading market, (ii) significant dilution pressure from warrants (especially zero-price feature), (iii) further share issuance if a future share-combination event resets the Floor Price, (iv) difficulty raising capital or executing acquisitions under the current capital structure.